These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3956529)

  • 1. Fast, low-temperature preparation of carrier-free 17-123I-heptadecanoic acid applied for liver and heart scintigraphy.
    Mertens J; Vanryckeghem W; Bossuyt A
    Eur J Nucl Med; 1986; 11(9):361-2. PubMed ID: 3956529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expanded evaluation possibilities of 123I-heptadecanoic acid metabolic studies of the myocardium using parametric scintigraphy].
    Hliscs R; Franke WG; Ulrich J; Lohr E; Mende T
    Radiol Diagn (Berl); 1988; 29(3):496-8. PubMed ID: 3186967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myocardial scintigraphy using omega-I-123 heptadecanoic acid (Rossendorf) in patients with coronary disease].
    Lohr E; Mende T; Steinbach J; Hliscs R; Anders G; Franke WG; Beyer GJ
    Cor Vasa; 1988; 30(1):18-26. PubMed ID: 3378445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance.
    Turpeinen AK; Kuikka JT; Vanninen E; Uusitupa MI
    Diabetologia; 1997 May; 40(5):541-9. PubMed ID: 9165222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of beta-methyl-heptadecanoic acid in the perfused rat heart and liver.
    Fink GD; Montgomery JA; David F; Garneau M; Livni E; Elmaleh D; Strauss HW; Brunengraber H
    J Nucl Med; 1990 Nov; 31(11):1823-30. PubMed ID: 2230995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectoris.
    van der Wall EE; Heidendal GA; den Hollander W; Westera G; Roos JP
    Postgrad Med J; 1983; 59 Suppl 3():38-40. PubMed ID: 6647209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [123-I-labeled fatty acids for myocardial functional diagnosis].
    Machulla HJ; Knust EJ
    Radiologe; 1984 Jun; 24(6):264-71. PubMed ID: 6473760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacing and the non-invasive evaluation of myocardial fatty acid metabolism by means of 17-123I-heptadecanoic acid scintigraphy.
    Duwel CM; Visser FC; van Eenige MJ; Roos JC; Roos JP
    Nuklearmedizin; 1988 Oct; 27(5):204-8. PubMed ID: 3194233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of radioiodinated heptadecanoic acid and metabolites in the normal and ischaemic canine heart.
    Visser FC; van Eenige MJ; Westera G; den Hollander W; Roos JP
    Eur Heart J; 1985 Aug; 6 Suppl B():97-101. PubMed ID: 4085512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-Iodine-123 iodoheptadecanoic acid for metabolic liver studies in humans.
    Höck A; Spohr G; Schmitz M; Notohamiprodjo G; Porschen R; Vyska K; Freundlieb C; Shreeve WW; Feinendegen LE
    J Nucl Med; 1986 Oct; 27(10):1533-9. PubMed ID: 3760977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of glucose on the myocardial time-activity curve during 17-iodo-123 heptadecanoic acid scintigraphy.
    Duwel CM; Visser FC; van Eenige MJ; van der Lugt HA; Roos JP
    Nucl Med Commun; 1987 Apr; 8(4):207-15. PubMed ID: 3684099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination.
    Lüthy P; Chatelain P; Papageorgiou I; Schubiger A; Lerch RA
    J Nucl Med; 1988 Jun; 29(6):1088-95. PubMed ID: 3373317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myocardial elimination rate of radioiodinated heptadecanoic acid.
    Visser FC; Westera G; van Eenige MJ; Van der Wall EE; Den Hollander W; Roos JP
    Eur J Nucl Med; 1985; 10(3-4):118-22. PubMed ID: 3996438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of myocardial fatty acid metabolism by iodine-123 heptadecanoic acid kinetics.
    Fridrich L
    J Nucl Med; 1987 May; 28(5):925-6. PubMed ID: 3572552
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of myocardial fatty acid metabolism by iodine-123 heptadecanoic acid kinetics.
    Feinendegen LE
    J Nucl Med; 1987 May; 28(5):924-5. PubMed ID: 3572551
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of time-activity curves related to myocardial metabolism. The case of 123I-heptadecanoic acid.
    van Eenige MJ; Visser FC; Karreman AJ; Bezemer PD; Westera G; van Lingen A; Roos JP
    Nucl Med Commun; 1991 Feb; 12(2):115-25. PubMed ID: 2002959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research on the demonstration of the portal venous system and its collaterals using dynamic images of liver scintigraphy].
    Ikoma N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Nov; 46(11):1302-13. PubMed ID: 3029664
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.
    Sasaki N; Shiomi S; Iwata Y; Nishiguchi S; Kuroki T; Kawabe J; Ochi H
    J Nucl Med; 1999 Oct; 40(10):1652-6. PubMed ID: 10520705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid.
    Jalilian AR; Akhlaghi M; Mirzaii M; Karimian AR
    Nucl Med Rev Cent East Eur; 2006; 9(2):108-13. PubMed ID: 17304472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201 per rectal scintigraphy improves prognostic evaluation in alcoholic liver cirrhosis of low and mid severity.
    Urbain D; Botembe N; Muls V; Makhoul E; Ham HR
    Am J Gastroenterol; 1995 Sep; 90(9):1461-4. PubMed ID: 7661170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.